Golnaz Moazami, M.D.
Neuro-ophthalmology Physician · New York, NY
Golnaz Moazami, M.D. is a neuro-ophthalmology physician with a practice address in New York, New York, and NPI 1427075407, issued on Jul 16, 2006. Check the license (New York 203828, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Golnaz Moazami
- Credential
- M.D.
- Primary taxonomy
- Neuro-ophthalmology Physician 207WX0109X
- License numbers
- 203828 NY
203828-1 NY
Self-reported in NPPES; status is on the state search - Practice location
- 210 E 64TH St FL 6, New York, NY 10065
- Phone
- (917) 200-8900
- Enumerated
- Jul 16, 2006
- Record last updated
- Feb 28, 2024
- Fax
- (917) 338-5088
- Medicare enrollment
- Enrolled (PECOS I20031104000328); accepts Medicare assignment
- Medical or professional school
- Columbia University College Of Physicians And Surgeons, 1991
- Entity
- Type 1 · individual
8 nearest neuro-ophthalmology physician records → All 19 in New York → Look up another NPI →
Verify Golnaz Moazami in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 203828Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
5.1 times the Medicare Part D claims of the average neuro-ophthalmology physician in 2024
1,724 Medicare Part D claims for 435 beneficiaries, against an average of 335 among the 140 providers of this specialty who prescribed in Part D. Brand-name drugs were 43% of claims.
Most prescribed
- Latanoprost485 claims
- Timolol Maleate177 claims
- Restasis121 claims
- Lumigan67 claims
- Dorzolamide-Timolol61 claims
- Dorzolamide Hcl60 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 0 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Bills Medicare through one group practice
- North Shore-Lij Medical PCNew York, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Golnaz Moazami among 19 neuro-ophthalmology physician records in New York
Golnaz Moazami, M.D. is one of 19 neuro-ophthalmology physician records with a practice address in New York. 95% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 5% of them.
- NPI issued2006 · 5% of these records are older, 79% newer
- In a Medicare fileYes · 95% of these records are
- In the CMS Doctors and Clinicians fileYes · 89% of these records are
- Graduated1991 · median 2010 among the 17 with a school on file
- Record last updated2024 · 26% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207WX0109X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Neuro-ophthalmology Physician providers in New York
There are 19 neuro-ophthalmology physician records in New York.
All 19 in New York → Every provider in New York → Neuro-ophthalmology Physician nationwide →
The 8 neuro-ophthalmology physician records with the nearest ZIP codes
- Meital Ben Dov, MD.New York, NY 100321275287195
- Kevin Yan, MDNew York, NY 100291265061691
- Marc Dinkin, MDNew York, NY 100211215953740
- Erin Lanzo, MDNew York, NY 100211073176863
- Rita Okumu, MDNew York, NY 100211710477005
- Cristiano Oliveira, M.D.New York, NY 100211841485364
- John Paddock, MDNew York, NY 100211265962872
- Andrew Silverman, MD, MHSNew York, NY 100211275169260
Common questions
What is Golnaz Moazami, M.D.'s NPI number?
Golnaz Moazami, M.D.'s National Provider Identifier (NPI) is 1427075407, issued on Jul 16, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Golnaz Moazami, M.D. located?
The NPPES record lists a practice address at 210 E 64TH St FL 6, New York, NY, 10065. Phone: (917) 200-8900. Providers update this record themselves, so call before visiting.
How can I verify Golnaz Moazami, M.D.'s license?
NPPES lists New York license number 203828, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Golnaz Moazami, M.D. prescribe under Medicare Part D?
In 2024, Golnaz Moazami, M.D. had 1,724 Medicare Part D claims for 435 beneficiaries; the average among neuro-ophthalmology physician prescribers was 335. Part D covers Medicare prescriptions only.
What is Golnaz Moazami, M.D.'s MIPS final score?
The 2023 MIPS final score is 0 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.